This is the first study to describe the capacity of RL leaf SC-CO2 extracts to inhibit enzymes related to inflammation (XO, LOX, hyaluronidase) and diabetes (α -amylase, α-glucosidase). This evidence concerns the gene LOX and diabetes mellitus.